Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant. [electronic resource]
- American journal of hematology 10 2016
- E442-7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1096-8652
10.1002/ajh.24487 doi
Adult Aged Disease Progression Disease-Free Survival Female Gene Deletion Hematopoietic Stem Cell Transplantation--methods Humans Immunologic Factors--therapeutic use Male Middle Aged Multiple Myeloma--genetics Proteasome Inhibitors--therapeutic use Recurrence Survival Analysis Transplantation, Autologous Treatment Outcome Tumor Suppressor Protein p53--genetics